Testing effectiveness (Phase 2)Looking for participantsNCT06923072
What this trial is testing
Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement
Who this might be right for
Kohlmeier-Degos DiseaseMalignant Atrophic PapulosisDegos Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI) 12